---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-145714"
form_type: "8-K"
ticker: "REPL"
cik: "0001737953"
company_name: "Replimune Group, Inc."
filed_at: "2021-12-02T23:59:59+00:00"
generated_at: "2026-06-28T04:12:27.156547+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Replimune appoints Christy Oliger to Board effective Dec 1, 2021

## Summary
- Oliger appointed to Board, increasing size to 11; also joins Audit and R&D Committees.
- She brings ~30 yrs pharma/biotech experience, most recently SVP Oncology at Genentech.
- Receives $40k annual Board cash retainer, plus $7.5k Audit, $6k R&D; stock option for 33k shares at $28.01.
- Option vests 25% on 1st anniversary, then monthly over 24 months.
- Appointment effective Dec 1, 2021; will stand for election at 2022 annual meeting.

## SEC filing metadata
- accession: 0001104659-21-145714
- form_type: 8-K
- ticker: REPL
- cik: 0001737953
- company_name: Replimune Group, Inc.
- filed_at: 2021-12-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737953/000110465921145714/0001104659-21-145714-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737953/000110465921145714/tm2134404d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-145714
- JSON: https://secwatch.observer/filing/0001104659-21-145714.json
- Plain text: https://secwatch.observer/filing/0001104659-21-145714.txt

## Key facts
- Executive change
  Christy Oliger was appointed as Director at Replimune Group, Inc..
  - Action: appointed
  - Role: Director
  source text: the Board of Directors of the Company (the “ Board ”) increased the size of the Board from ten members to eleven and filled the newly created vacancy on the Board by appointing Christy Oliger as a director of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1737953/000110465921145714/0001104659-21-145714-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.